Uniplan Investment Counsel, Inc. Medi Wound Ltd. Transaction History

Uniplan Investment Counsel, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.35 - $9.8 $7,134 - $51,793	-5,285 Reduced 0.73%	714,245 $992,000
Q2 2022 Aug 15, 2022	BUY	$1.33 - $2.35 $320,507 - $566,310	240,983 Added 50.36%	719,530 $1.32 Million
Q1 2022 May 16, 2022	BUY	$1.86 - $3.24 $4,278 - $7,452	2,300 Added 0.48%	478,547 $952,000
Q4 2021 Feb 14, 2022	BUY	$2.2 - $4.01 $8,879 - $16,184	4,036 Added 0.85%	476,247 $1.12 Million
Q3 2021 Nov 15, 2021	SELL	$3.34 - $4.63 $19,211 - $26,631	-5,752 Reduced 1.2%	472,211 $1.58 Million
Q2 2021 Aug 13, 2021	BUY	$3.38 - $5.71 $1.62 Million - $2.73 Million	477,963 New	477,963 $1.83 Million

Ticker MDWD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,735,200
Market Cap $707M
Description
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hosp...

Get notified when there are updates to the investment portfolio of Uniplan Investment Counsel, Inc., based on Form 13F filings with the SEC.

Stay updated on Uniplan Investment Counsel, Inc. with notifications on news.